Immunological studies in patients with alopecia receiving dinitrochlorobenzene and cimetidine therapy
β Scribed by K. Thestrup-Pedersen; S. Bisballe; J. R. Jensen; H. Zachariae
- Publisher
- Springer-Verlag
- Year
- 1982
- Tongue
- English
- Weight
- 361 KB
- Volume
- 273-273
- Category
- Article
- ISSN
- 0340-3696
No coin nor oath required. For personal study only.
β¦ Synopsis
Twenty-one patients with alopecia were screened for the immune reactivity of their peripheral blood lymphocytes. Generally, patients had only eczematous reactions when rather strong solutions of dinitrochlorobenzene (DNCB) were applied. One-third of the patients had lymphocytes with in vitro reactivity towards dinitrofluorobenzene-albumin in a lymphocyte transformation test. The percentage of T lymphocyte subpopulations in blood was normal, together with a normal in vitro function after mitogen and antigen stimulation. Six of the patients were treated with 1 g cimetidine daily for 6weeks. We could not find clinical or immunological changes during the therapy. The findings are discussed in relation to other immunological studies of patients with alopecia and the eventual effect of cimetidine on the immune system.
π SIMILAR VOLUMES
## Background: Photodynamic therapy (pdt) is a new modality involving the administration of a photosensitizer, or photosensitizer precursor, followed by its activation with light to generate a therapeutic effect. 5-aminolaevulinic acid (ala) is a photosensitizer precursor that is transformed by cel